Track the Avicanna Inc. share price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the oversight of SEDI. Operating in the Health Care sector, Avicanna Inc. has logged 27 insider filings. Market capitalisation: €17m. The latest transaction was disclosed on 24 June 2026 (50 - Grant of options). Among the most active insiders: Hilborn, Nicholas. All data is accessible without an account.
27
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
50Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,737 of 29,053 companies
23.5
score / 100
Value
15
Quality
32
FCF yld-8.2%
Earn yld-16%
EV/EBITDA·
ROE-30%
Gross mgn53%
Net mgn-11%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
333,000 shares@ CA$0.150.38% mcap72.6% of flowCommon SharesTSXSEDI:4735142
Canonical exit: 10 Sept 2026 (T+90)
25 of 27 declarations
About Avicanna Inc.
Avicanna Inc. is a Canadian company focused on the development of pharmaceutical products derived from cannabis. It specializes in research, formulation, and commercialization of innovative therapeutic solutions.